Head Neck Cancer, Squamous Cell Cancer of Head and Neck (SCCHN),
Location: Charlottesville VA
Sponsor: University of Virginia
Sex: All
Age: 18 - 70+
Code: NCT07405645
Recruiting
Digital Mindfulness for Young Adults With Type 1 Diabetes
for
Type 1 Diabetes (T1D), Diabetes Secondary to Pancreatitis
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 30
Code: NCT07062887
Recruiting
Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
for
Human Papillomavirus-Negative Neck Squamous Cell Carcinoma,
Location: Jacksonville FL
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06997094
Phase1, Recruiting
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
for
Adenocarcinoma, Carcinoma, Pancreatic Ductal
Location: Shirley NY, Albany NY, East Brunswick NJ, Morristown NJ,
Sponsor: Corcept Therapeutics
Sex: All
Age: 18+
Code: NCT07259317
Phase2, Recruiting
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
for
Head and Neck Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07101432
Phase1, Recruiting
Interested in new pancreatic cancer trials?
Get alerts for new trials in your area by subscribing now
Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
for
Pancreatic Ductal Adenocarcinoma,
Location: Vancouver
Sponsor: British Columbia Cancer Agency
Sex: All
Age: 18+
Code: NCT06574620
Recruiting
Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma
for
Cutaneous, Head and Neck Cancer Squamous Cell Carcinoma
Location: London
Sponsor: David Palma
Sex: All
Age: 18+
Code: NCT07337161
Recruiting
Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer
for
Head and Neck Carcinoma
Location: Pittsburgh PA
Sponsor: Yvonne Mowery
Sex: All
Age: 18+
Code: NCT07227792
Recruiting
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Richmond VA, Pittsburgh PA, Atlanta GA, Cincinnati OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06980038
Phase2, Recruiting
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
for
Head and Neck Neoplasms, Carcinoma, Squamous Cell,
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT06912087
Phase1, Recruiting
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
for
Velopharyngeal Insufficiency, Head and Neck Cancer,
Location: Charlottesville VA
Sponsor: Vanessa Torrecillas
Sex: All
Age: 18+
Code: NCT07264036
Recruiting
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, Hartford CT, New Haven CT, Mineola NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase3, Recruiting
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
for
Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, The Bronx NY, Philadelphia PA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All
Age: 18 - 70+
Code: NCT07219212
Phase1, Recruiting
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
for
Head and Neck Squamous Cell Carcinoma HNSCC,
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Sutro Biopharma, Inc.
Sex: All
Age: 18+
Code: NCT07227168
Phase1, Recruiting
Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma
for
Metastatic Pancreatic Adenocarcinoma,
Location: Charleston SC
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT07076212
Phase2, Recruiting
Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer
for
Pancreatic Ductal Adenocarcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07226154
Recruiting
Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
for
Advanced Head and Neck Squamous Cell Carcinoma,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT07094685
Phase2, Recruiting
Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema
for
Head and Neck Cancer, Lymphedema of the Head and Neck
Location: Philadelphia PA, Nashville TN
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT06837480
Recruiting
Survivorship After HNC: A Randomized Controlled Trial Evaluating Patient Care and Adherence to Follow-up